← Leaderboards
Stephen D Miller
Northwestern University
$28,077,677
Attributed
$36,751,554
Total exposure
20
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$45,654,827 · 21
By mechanism
R01$25,488,798 · 9
P01$11,141,130 · 4
U01$4,447,237 · 1
T32$2,444,533 · 1
R21$2,108,128 · 5
R13$25,001 · 1
Top collaborators
- Lonnie D Shea14 shared
- Bernhard Josef Hering5 shared
- Xunrong Luo5 shared
- Brian J Popko5 shared
- Jayme Borensztajn2 shared
- Sookyong Koh2 shared
- John Varga2 shared
Most similar at Northwestern University
Same institution · by research overlap
- Brian J Popko$20,097,136
- William J Karpus$7,096,925
- Pamela Carpentier$56,123
Others in their field
Top investigators on “Multiple Sclerosis”
- David A. Hafler · Brigham And Women'S Hospital$33,720,341
- Vijay K Kuchroo · Brigham And Women'S Hospital$32,935,587
- Stephen L Hauser · University Of California San Francisco$32,469,388
- Katerina Akassoglou · University Of California San Diego$24,525,425
- Abdolmohamad Rostami · Thomas Jefferson University$23,969,638
- Fred D Lublin · Mount Sinai School Of Medicine Of Nyu$22,560,310
Research focus
Multiple SclerosisAntigensT-LymphocyteCellsMyelinCytokineImmuneMediatingChronicPeptidesResponseInflammatoryRegulatory T-LymphocyteRelapseExperimental Autoimmune EncephalomyelitisBaseAutoimmune DiseasesCd4 Positive T LymphocytesPhenotypeRegulationAnergyPreventAntigen-Presenting CellsMolecular
Grant awards (118)
Allergen Loaded Nanoparticles for Food Allergy Tolerance$732,841
R01 · FY2024 · AI
Allergen Loaded Nanoparticles for Food Allergy Tolerance$743,761
R01 · FY2023 · AI
Allergen Loaded Nanoparticles for Food Allergy Tolerance$899,903
R01 · FY2022 · AI
Allergen Loaded Nanoparticles for Food Allergy Tolerance$764,326
R01 · FY2021 · AI
Regulation of CD4+ T cell-mediated Demyelination Following Oligo Ablation$417,645
R01 · FY2021 · NS · contact PI
Regulation of Neuromyelitis Optica via Tolerance Induced by PLG Nanoparticles Encapsulating Aquaporin 4 Epitopes$198,333
R21 · FY2021 · AI · contact PI
Allergen Loaded Nanoparticles for Food Allergy Tolerance$785,246
R01 · FY2020 · AI
Regulation of CD4+ T cell-mediated Demyelination Following Oligo Ablation$419,383
R01 · FY2020 · NS · contact PI
Regulation of Neuromyelitis Optica via Tolerance Induced by PLG Nanoparticles Encapsulating Aquaporin 4 Epitopes$237,000
R21 · FY2020 · AI · contact PI
Combining Immune Tolerance and Myelin Repair Therapy in T cell-driven MS Models$197,500
R21 · FY2020 · AI · contact PI
Regulation of CD4+ T cell-mediated Demyelination Following Oligo Ablation$421,296
R01 · FY2019 · NS · contact PI
Combining Immune Tolerance and Myelin Repair Therapy in T cell-driven MS Models$237,000
R21 · FY2019 · AI · contact PI
Regulation of the Profibrotic Mechanisms of MACRO+ Myeloid Cells in Scleroderma$173,800
R21 · FY2019 · AR · contact PI
Antigen loaded particles for tolerance induction$513,529
R01 · FY2018 · EB
Regulation of CD4+ T cell-mediated Demyelination Following Oligo Ablation$423,174
R01 · FY2018 · NS · contact PI
Regulation of the Profibrotic Mechanisms of MACRO+ Myeloid Cells in Scleroderma$208,560
R21 · FY2018 · AR · contact PI
Antigen loaded particles for tolerance induction$526,590
R01 · FY2017 · EB
Regulation of CD4+ T cell-mediated Demyelination Following Oligo Ablation$440,219
R01 · FY2017 · NS · contact PI
Alloantigen Delivery Via ECDI-Fixed Cells For Tolerance To Monkey Islet Grafts$869,444
U01 · FY2016 · AI
Antigen loaded particles for tolerance induction$538,312
R01 · FY2016 · EB
Immunoregulation and Pathology of Chronic-Relapsing EAE$337,969
R01 · FY2016 · NS · contact PI
Novel Therapies for Epilepsy Using Biodegradable Immune-Modifying Nanoparticles$192,155
R21 · FY2016 · NS · contact PI
Alloantigen Delivery Via ECDI-Fixed Cells For Tolerance To Monkey Islet Grafts$999,893
U01 · FY2015 · AI
Antigen loaded particles for tolerance induction$563,493
R01 · FY2015 · EB
Immunoregulation and Pathology of Chronic-Relapsing EAE$337,969
R01 · FY2015 · NS · contact PI
Novel Therapies for Epilepsy Using Biodegradable Immune-Modifying Nanoparticles$244,405
R21 · FY2015 · NS · contact PI
Alloantigen Delivery Via ECDI-Fixed Cells For Tolerance To Monkey Islet Grafts$869,444
U01 · FY2014 · AI
Immunoregulation and Pathology of Chronic-Relapsing EAE$334,588
R01 · FY2014 · NS · contact PI
Innate Regulation and CD4+Th1/17 Immunity in TMEV-Induced Demyelination$323,652
R01 · FY2014 · NS · contact PI
Antigen Loaded Particles for Tolerance Induction$262,847
R01 · FY2014 · EB
Antigen Loaded Particles for Tolerance Induction$238,480
R01 · FY2014 · EB
Alloantigen Delivery Via ECDI-Fixed Cells For Tolerance To Monkey Islet Grafts$839,012
U01 · FY2013 · AI
Antigen Loaded Particles for Tolerance Induction$475,985
R01 · FY2013 · EB
Immunoregulation and Pathology of Chronic-Relapsing EAE$326,140
R01 · FY2013 · NS · contact PI
Innate Regulation and CD4+Th1/17 Immunity in TMEV-Induced Demyelination$315,480
R01 · FY2013 · NS · contact PI
Alloantigen Delivery Via ECDI-Fixed Cells For Tolerance To Monkey Islet Grafts$869,444
U01 · FY2012 · AI
Antigen Loaded Particles for Tolerance Induction$505,900
R01 · FY2012 · EB
Immunoregulation and Pathology of Chronic-Relapsing EAE$337,969
R01 · FY2012 · NS · contact PI
Innate Regulation and CD4+Th1/17 Immunity in TMEV-Induced Demyelination$326,922
R01 · FY2012 · NS · contact PI
Antigen Loaded Particles for Tolerance Induction$506,879
R01 · FY2011 · EB
Innate Regulation and CD4+Th1/17 Immunity in TMEV-Induced Demyelination$326,922
R01 · FY2011 · NS · contact PI
Immunoregulation and Pathology of Chronic-Relapsing EAE$323,706
R01 · FY2011 · NS · contact PI
Immunology and Molecular Pathogenesis Training Program$247,754
T32 · FY2011 · AI · contact PI
An Immune Tolerance Strategy for Prevention and Treatment of Atherosclerosis$190,625
R21 · FY2011 · HL
Innate Regulation and CD4+Th1/17 Immunity in TMEV-Induced Demyelination$333,594
R01 · FY2010 · NS · contact PI
Immunoregulation and Pathology of Chronic-Relapsing EAE$327,010
R01 · FY2010 · NS · contact PI
Pathogenesis and Immunoregulation of PLP-Induced R-EAE$322,075
R01 · FY2010 · NS · contact PI
Immunology and Molecular Pathogenesis Training Program$239,534
T32 · FY2010 · AI · contact PI
An Immune Tolerance Strategy for Prevention and Treatment of Atherosclerosis$228,750
R21 · FY2010 · HL
Immunoregulation and Pathology of Chronic-Relapsing EAE$330,313
R01 · FY2009 · NS · contact PI
Pathogenesis and Immunoregulation of PLP-Induced R-EAE$325,608
R01 · FY2009 · NS · contact PI
Immunology and Molecular Pathogenesis Training Program$226,655
T32 · FY2009 · AI · contact PI
Immunoregulation and Pathology of Chronic-Relapsing EAE$330,313
R01 · FY2008 · NS · contact PI
Pathogenesis and Immunoregulation of PLP-Induced R-EAE$325,869
R01 · FY2008 · NS · contact PI
Mechanisms of CD4+CD25+ T Regulatory Cells in EAE$305,492
R01 · FY2008 · NS · contact PI
A Virus-induced Molecular Mimicry Model of MS$280,116
R01 · FY2008 · NS · contact PI
Immunology and Molecular Pathogenesis Training Program$239,138
T32 · FY2008 · AI · contact PI
CNS Damage from Theiler's Virus Persistence: MS Model$1,286,152
P01 · FY2007 · NS · contact PI
Immunoregulation and Pathology of Chronic-Relapsing EAE$330,313
R01 · FY2007 · NS · contact PI
Pathogenesis and Immunoregulation of PLP-Induced R-EAE$326,115
R01 · FY2007 · NS · contact PI
Mechanisms of CD4+CD25+ T Regulatory Cells in EAE$306,642
R01 · FY2007 · NS · contact PI
A Virus-induced Molecular Mimicry Model of MS$281,956
R01 · FY2007 · NS · contact PI
Immunology and Molecular Pathogenesis Training Program$244,970
T32 · FY2007 · AI · contact PI
CORE A: Administrative Core$183,737
P01 · FY2007 · NS · contact PI
CD4+ T cell Immunity in TMEV-Induced Demyelination$183,735
P01 · FY2007 · NS · contact PI
CNS Damage from Theiler's Virus Persistence: MS Model$1,324,554
P01 · FY2006 · NS · contact PI
Pathogenesis and Immunoregulation of PLP-Induced R-EAE$337,644
R01 · FY2006 · NS · contact PI
Mechanisms of CD4+CD25+ T Regulatory Cells in EAE$316,984
R01 · FY2006 · NS · contact PI
A Virus-induced Molecular Mimicry Model of MS$292,271
R01 · FY2006 · NS · contact PI
CD4+ T cell Immunity in TMEV-Induced Demyelination$144,717
P01 · FY2006 · NS · contact PI
CORE A: Administrative Core$144,717
P01 · FY2006 · NS · contact PI
FASEB Summer Conference on 'Autoimmunity'$1
R13 · FY2006 · AI · contact PI
CNS Damage from Theiler's Virus Persistence: MS Model$1,355,993
P01 · FY2005 · NS
Mechanisms of CD4+CD25+ T Regulatory Cells in EAE$325,825
R01 · FY2005 · NS
A Virus-induced Molecular Mimicry Model of MS$301,245
R01 · FY2005 · NS
Pathogenesis and Immunoregulation of PLP-Induced R-EAE$293,540
R01 · FY2005 · NS
Immunology and Molecular Pathogenesis Training Program$225,200
T32 · FY2005 · AI
CORE A: Administrative Core$144,655
P01 · FY2005 · NS
CD4+ T cell Immunity in TMEV-Induced Demyelination$144,655
P01 · FY2005 · NS
FASEB Summer Conference on 'Autoimmunity'$25,000
R13 · FY2005 · AI
CNS Damage from Theiler's Virus Persistence: MS Model$1,013,024
P01 · FY2004 · NS
CNS Damage from Theiler's Virus Persistence: MS Model$355,531
P01 · FY2004 · NS
Immunoregulation and Pathology of Chronic-Relapsing EAE$351,050
R01 · FY2004 · NS
Pathogenesis and Immunoregulation of PLP-Induced R-EAE$294,522
R01 · FY2004 · NS
A VIRUS-INDUCED MOLECULAR MIMICRY MODEL OF MS$294,000
R01 · FY2004 · NS
Immunology and Molecular Pathogenesis Training Program$229,529
T32 · FY2004 · AI
CORE A: Administrative Core$144,717
P01 · FY2004 · NS
CD4+ T cell Immunity in TMEV-Induced Demyelination$144,717
P01 · FY2004 · NS
CNS Damage from Theiler's Virus Persistence: MS Model$1,014,791
P01 · FY2003 · NS
Immunoregulation and Pathology of Chronic-Relapsing EAE$351,050
R01 · FY2003 · NS
B7/CD28/CTLA-4 COSTIMULATION IN PATHOGENESIS OF R-EAE$348,700
R01 · FY2003 · NS
Pathogenesis and Immunoregulation of PLP-Induced R-EAE$295,460
R01 · FY2003 · NS
A VIRUS-INDUCED MOLECULAR MIMICRY MODEL OF MS$294,000
R01 · FY2003 · NS
Immunology and Molecular Pathogenesis Training Program$218,772
T32 · FY2003 · AI
CORE A: Administrative Core$144,969
P01 · FY2003 · NS
CD4+ T cell Immunity in TMEV-Induced Demyelination$144,969
P01 · FY2003 · NS
CNS DAMAGE FROM THEILERS VIRUS PERSISTENCE--MS MODEL$876,017
P01 · FY2002 · NS
Immunoregulation and Pathology of Chronic-Relapsing EAE$351,050
R01 · FY2002 · NS
B7/CD28/CTLA-4 COSTIMULATION IN PATHOGENESIS OF R-EAE$348,700
R01 · FY2002 · NS
Pathogenesis and Immunoregulation of PLP-Induced R-EAE$296,353
R01 · FY2002 · NS
A VIRUS-INDUCED MOLECULAR MIMICRY MODEL OF MS$294,000
R01 · FY2002 · NS
T CELL IMMUNITY IN TMEV INDUCED DEMYELINATION$255,866
P01 · FY2002 · NS
Immunology and Molecular Pathogenesis Training Program$207,763
T32 · FY2002 · AI
CNS DAMAGE FROM THEILERS VIRUS PERSISTENCE--MS MODEL$850,998
P01 · FY2001 · NS
Immunoregulation and Pathology of Chronic-Relapsing EAE$351,050
R01 · FY2001 · NS
B7/CD28/CTLA-4 COSTIMULATION IN PATHOGENESIS OF R-EAE$348,700
R01 · FY2001 · NS
A VIRUS-INDUCED MOLECULAR MIMICRY MODEL OF MS$294,000
R01 · FY2001 · NS
PATHOGENESIS AND IMMUNOREGULATION OF PLP-INDUCED R-EAE$272,481
R01 · FY2001 · NS
T CELL IMMUNITY IN TMEV INDUCED DEMYELINATION$255,866
P01 · FY2001 · NS
Immunology and Molecular Pathogenesis Training Program$188,945
T32 · FY2001 · AI
CNS DAMAGE FROM THEILERS VIRUS PERSISTENCE--MS MODEL$826,213
P01 · FY2000 · NS
B7/CD28/CTLA-4 COSTIMULATION IN PATHOGENESIS OF R-EAE$348,700
R01 · FY2000 · NS
A VIRUS-INDUCED MOLECULAR MIMICRY MODEL OF MS$294,000
R01 · FY2000 · NS
IMMUNOREGULATION AND PATHOLOGY OF CHRONIC RELAPSING EAE$282,385
R01 · FY2000 · NS
PATHOGENESIS AND IMMUNOREGULATION OF PLP-INDUCED R-EAE$264,546
R01 · FY2000 · NS
T CELL IMMUNITY IN TMEV INDUCED DEMYELINATION$200,537
P01 · FY2000 · NS
TRAINING PROGRAM IN IMMUNOLOGY &MOLECULAR PATHOGENESIS$176,273
T32 · FY2000 · AI
PATHOGENESIS AND IMMUNOREGULATION OF PLP-INDUCED R-EAE$50,000
R01 · FY2000 · NS